Related references
Note: Only part of the references are listed.Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease
Syed Z. Imam et al.
JOURNAL OF NEUROSCIENCE (2011)
Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation
Fanjun Meng et al.
MOLECULAR NEURODEGENERATION (2011)
Gene-environment interactions: Key to unraveling the mystery of Parkinson's disease
Hui-Ming Gao et al.
PROGRESS IN NEUROBIOLOGY (2011)
Gene-Environment Interactions in Parkinson's Disease: The Importance of Animal Modeling
M. P. Horowitz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Gene-environment interactions in Parkinson's disease and other forms of parkinsonism
Jeffery M. Vance et al.
NEUROTOXICOLOGY (2010)
Parkin protects against mitochondrial toxins and β-amyloid accumulation in skeletal muscle cells
KM Rosen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dopamine covalently modifies and functionally inactivates parkin
MJ LaVoie et al.
NATURE MEDICINE (2005)
Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death
HS Ko et al.
JOURNAL OF NEUROSCIENCE (2005)
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: Implications for Lewy body formation
KL Lim et al.
JOURNAL OF NEUROSCIENCE (2005)
Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity
A Yamamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Parkin gene therapy for α-synucleinopathy:: A rat model of Parkinson's disease
M Yamada et al.
HUMAN GENE THERAPY (2005)
Parkin genetics: one model for Parkinson's disease
IF Mata et al.
HUMAN MOLECULAR GENETICS (2004)
Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
HB Jiang et al.
HUMAN MOLECULAR GENETICS (2004)
BAG5 inhibits parkin and enhances dopaminergic neuron degeneration
SK Kalia et al.
NEURON (2004)
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease
C Lo Bianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nitrosative stress linked to sporadic Parkinson's disease:: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity
DD Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
How does parkin ligate ubiquitin to Parkinson's disease? First in molecular medicine review series
PJ Kahle et al.
EMBO REPORTS (2004)
Parkin attenuates manganese-induced dopaminergic cell death
Y Higashi et al.
JOURNAL OF NEUROCHEMISTRY (2004)
S-nitrosylation of Parkin regulates ubiquitination and compromises Parkin's protective function
KKK Chung et al.
SCIENCE (2004)
Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system
L Petrucelli et al.
ANNALS OF MEDICINE (2004)
Molecular pathways of neurodegeneration in Parkinson's disease
TM Dawson et al.
SCIENCE (2003)
Role of nitric oxide in rotenone-induced nigro-striatal injury
Y He et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function
YC Tsai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nitric oxide and reactive oxygen species in Parkinson's disease
K Tieu et al.
IUBMB LIFE (2003)
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: Role of neuroinflammation
B Liu et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Update on Parkinson disease
A Siderowf et al.
ANNALS OF INTERNAL MEDICINE (2003)
Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila
YF Yang et al.
NEURON (2003)
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
T Foroud et al.
NEUROLOGY (2003)
Parkin is a component of an SCF-like ubipuitin ligase complex and protects postmitotic neurons from kainate excitotoxicity
JF Staropoli et al.
NEURON (2003)
Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death
F Darios et al.
HUMAN MOLECULAR GENETICS (2003)
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
TB Sherer et al.
EXPERIMENTAL NEUROLOGY (2003)
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
H Ischiropoulos et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses
DJ Moore et al.
NEUROMOLECULAR MEDICINE (2003)
Parkin protects against the toxicity associated with mutant α-synuclein:: Proteasome dysfunction selectively affects catecholaminergic neurons
L Petrucelli et al.
NEURON (2002)
Functional association of the parkin gene promoter with idiopathic Parkinson's disease
AB West et al.
HUMAN MOLECULAR GENETICS (2002)
Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat
AL McCormack et al.
NEUROBIOLOGY OF DISEASE (2002)
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies
MG Schlossmacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures
KS McNaught et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Parkinson's disease and other α-synucleinopathies
M Goedert
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2001)
Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
H Shimura et al.
NATURE GENETICS (2000)
Association between early-onset Parkinson's disease and mutations in the parkin gene
CB Lücking et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
